In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- Plan in Works to Save Suffolk Downs Racing
- Espinoza Suspended for Awesome Again Ride
- Figures Decline at F-T Midlantic Fall Sale
- Two-Time Gr. I Winner Strategic Maneuver Dies
- Rosalind to Fasig-Tipton November Sale
- Desormeaux to Hospital After Kick by Horse
- Simulcast Conference: HD Options Progressing
- Record Prize Money Expected for NHC, NHC Tour
- Kay Outlines Recent Successes to NYRA Board
- Haskin: Thoughts on a Super Saturday